Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tocilizumab for Treatment of SARS Cov2 Pneumonia. Experience in a Private Health Center Facility in Buenos Aires City.

NCT05057962 is registered in ClinicalTrials.gov with Sanatorio Finochietto as lead sponsor.

NCT NCT05057962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05057962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tocilizumab for Treatment of SARS Cov2 Pneumonia. Experience in a Private Health Center Facility in Buenos Aires City.
Lead sponsor
Sanatorio Finochietto
Phase
Observational
Overall status
Completed
Start date
July 1, 2021
Completion date
May 4, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pneumonia, tocilizumab